ORESHACK KURT 4

What Happened

• Kurt Oreshack, General Counsel of Maravai LifeSciences (MRVI), acquired 776 shares of Class A common stock on 2026-05-15 at an average price of $2.84 per share, for a total purchase value of $2,204. The shares were acquired under the company's 2020 Employee Stock Purchase Plan (ESPP).

Key Details

• Transaction date: 2026-05-15
• Transaction type: Acquisition under ESPP (reported as "A" — grant/award/other acquisition)
• Price and amount: 776 shares at $2.84 each; total $2,204
• Shares owned after transaction: Not specified in the filing
• Footnote: Reporting person states this was a voluntary report and the acquisition was exempt under Rule 16b-3 (see footnote F1)
• Filing timing: Form 4 was filed 2026-05-22 for the 2026-05-15 transaction. This is later than the typical two business-day reporting window for insiders; the filing notes the reporting was voluntary.

Context

• This was an ESPP purchase — a routine way for employees to buy company stock at a set price; such purchases are commonly compensation-related and not necessarily a strong signal of personal investment conviction. The Rule 16b-3 exemption indicates the transaction is treated as a permitted company-plan acquisition for Section 16 purposes.